Clinical evidence
z-curcumin human pharmacokinetic study.
A randomised, double-blind, single-dose comparison assessing plasma curcumin exposure after powder, aqueous-liquid and native curcumin formats.
What was measured
Exposure, not outcomes.
The study measured how much curcumin reached plasma after a single 500 mg dose in three formats. Relative AUC reached up to 71× (powder) and 66× (aqueous liquid) versus native curcumin.
These are measures of absorption. They are not measures of a health benefit.
Ready to make your ingredients perform in the finished product?
Speak with our team about your ingredient, product and application — and see how the platform can support your workflow.